http://inothernewsradio.com/podcast/in-other-news-may-28-2018/
We focus in on the diligent complex investigative reporting that
examined failed oversight and corporate fraud perpetrated by a
multi-billion dollar biotech startup. The company is called Theranos.
Its founder was CEO Elizabeth Holmes. In early 2003, Holmes dropped out
of Stanford University and created Theranos after patenting an idea to
develop portable blood testing machines that use only a single drop of
blood. She rose to success and soon became known as the youngest female
billionaire. Despite the deals signed with consumer health companies,
federal approval, and raving New Yorker and Forbes articles calling
Holmes the next Steve Jobs, there were big problems behind the scenes.
Theranos blood test technology was exposed as error prone and inaccurate
by former employees. Some of the employees fearfully reached out to
Wall Street Journal reporter John Carreyrou and he began to investigate.
After three and a half years of tenacious reporting, his recently
published book Bad Blood: Secrets and Lies In A Silicon Valley Startup
now chronicles the hubris and criminal activity that led up to the
Theranos crater.
Guest – John Carreyrou is
a
member of The Wall Street Journal’s investigative reporting team. He
joined the Journal in 1999 and has been based in Brussels, Paris and New
York for the paper.
Mr. Carreyrou has covered a number of topics at the Journal, ranging
from Islamist terrorism when he was on assignment in Europe, to the
pharmaceutical industry. In 2015, he won a Pulitzer Prize for
Investigative Reporting with several colleagues for a series of articles
exposing fraud and abuse in Medicare, the federal health program for
the elderly and disabled. Earlier in his career, he was also part of a
Journal team that won a Pulitzer Prize for Explanatory Reporting for its
coverage of corporate scandals. His coverage of the Silicon Valley
blood-testing company Theranos has won George Polk, Gerald Loeb and
Barlett & Steele awards.
